The U.S. Food and Drug Administration (FDA) on Friday approved Biogen BIIB.O and Sage Therapeutics’ SAGE.O oral pill to treat postpartum depression (PPD) in adults.
FDA approves Biogen-Sage Therapeutics pill for postpartum depression
RELATED ARTICLES
Germany’s Scholz seals migration deal with Uzbekistan on Central Asia visit
U.S. says claims of CIA plot to kill Maduro are ‘categorically false’ after Venezuela arrests six foreigners
WWII Baltic Offensive: How Soviet Red Army Dealt a Stinging Blow to Third Reich
